Epitomics, Inc., an emerging biotechnology company, is dedicated to developing their breakthrough rabbit monoclonal antibody technology (RabMAb) for research, diagnostics and therapeutics. The Company has utilised a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality monoclonal antibodies that have the potential to be used in the broad areas of research, diagnostics and therapeutics.
Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the Company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle.
Isotype Controls
Epitomics also provide isotype control antibodies concentrated to matched their primary rabbit mAb for use in Flow cytometry and IHC. Each IgG control is provided at the same concentration as the primary antibody and in the same 100ul aliquot. Simply use the isotype control at the same dilution as the primary antibody.
When ordering please include the catalog number of the primary antibody that you would like the isotype control matched to. The generic isotype control code is ISO-XXXX.
Epitomics have launched a new selection of conjugated rabbit monoclonal antibodies to complement their extensive range of antibodies. Below is a list of their current offering:
